INGN, Not Even 1 Year Later…


INGN: The Biggest ‘Valuation’ Pig I know of in the Stock Market –June 25, 2018

Of course as subsequently noted I failed to take advantage, soon after taking a loss on my short instead as it was destined to rise another 100 bucks a share from that June post before it topped.

As a former participant in this company’s industry I knew it was an utter hog that the suits were passing off as a medical technology company or some such thing. I tried to hold out, really I did, after identifying it as a value pig in the 180s. But look how high they took it before the air came out.


Funnily enough these shops are now cutting this pig from still-ridiculous targets after its latest quarterly earnings and guidance disappointment.

This is a dirty business and I am not a great trader. These things I hold self-evident. But man, I was spectacularly right on this one along with fellow swine DDD, which was also written up from the vantage point of my former profession.

Subscribe to NFTRH Premium (monthly at USD $33.50 or a 14% discounted yearly at USD $345.00) for an in-depth weekly market report, interim market updates and NFTRH+ chart and trade setup ideas.

You can also keep up to date with actionable public content at by using the email form on the right sidebar and get even more by joining our free eLetter. Follow via Twitter @BiiwiiNFTRH, StockTwits or RSS.